Top Abstract Purchase Related
Home
>
Node
>
Subnode

The treatment of sudden deafness and Menière's disease with papaverin and low molecular weight dextran

Rossberg, G.; Krüger, E.C.

Laryngologie Rhinologie Otologie 56(2): 160-166

1977

ISSN/ISBN: 0340-1588
PMID: 139517
Document Number: 115268
This study is concerned with the mean hearing gain in 50 cases of sudden deafness and 40 cases of Menière's disease treated with different drugs and treated with Papaverin and low molecular weight dextran. The treatment of sudden deafness with Papaverin and low molecular dextran was more effective than different drugs. In cases of Menière's disease the treatment with different drugs was not effective, but Papaverin and low molecular dextran was significantly successful. Finally, it is concluded that treatment according to Spoendlin (1969) with Papaverin and low molecular dextran is superior to different drugs.

Document emailed within 1 workday
Secure & encrypted payments

Poser, R.; Hirche, H. 1992: Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo Hno 40(10): 396-399
Brossy, J.J.; Lewis, J.; Black, D. 1982: Low-molecular-weight dextran and puff-adder bites South African Medical Journal 62(11): 349-350
Wang, H.W. 1973: Low molecular weight dextran im epidemic hemorrhagic fever Zhonghua Yi Xue Za Zhi 6: 355-358
Matsuo, O.; Kawaguchi, T.; Kosugi, T.; Mihara, H. 1980: Effect of low molecular weight dextran sulphate on plasmin activity measured with S-2251 Acta Physiologica Latino Americana 30(3): 193-198
Tananov, A.T.; Zotikov, E.A.; Polushina, T.V.; Sirotkina, V.P. 1975: Comparative study of conglutinating properties of Soviet-made dextran of different molecular weight Problemy Gematologii i Perelivaniia Krovi 20(7): 59-60
Sukhanov, A.A.; Sukhanov, V.A. 1976: Use of law molecular weight dextran for prevention of thrombosis in surgical patients (review of the literature) Khirurgiia 1976(10): 133-135
Hall, C.E.; Ayachi, S.; Hall, O. 1971: Arthritis and other sequelae to intraperitoneally administered dextran in rats--relationship to molecular weight of the glucan Texas Reports on Biology and Medicine 29(3): 289-312
Garrett, K.O.; Pautler, S.V.; Johnson, P.C. 1993: The inability of low-molecular-weight dextran, aspirin, and prostaglandin E1 to inhibit monolayer platelet adhesion to polyethylene Journal of Laboratory and Clinical Medicine 122(2): 141-148
Evarts, C.M.; Feil, E.I. 1971: Thromboembolism after elective surgery of the hip. Detection, natural history, prophylaxis, and results with low molecular weight dextran Orthopedic Clinics of North America 2(1): 167-174
Wintch, R.; James, P.M.; Turner, C.; Vargish, T.; Anderson, B.; Meredith, J.H. 1977: Canine kidney preservation: comparison of "intracellular", "extracellular," and high molecular weight dextran flushing solutions Southern Medical Journal 70(12): 1414-1417
Moore, R.M.; Bertone, A.L.; Muir, W.W. 1996: Effect of high-molecular weight dextran macromolecules on low-flow ischemia and reperfusion of the large colon in horses American Journal of Veterinary Research 57(7): 1067-1073
Beutter, P.; Guinard, F.; Jalbert, D.; Marsac, A.; Morin, R.; Sauvage, J.P.; Soudant, J. 1990: Value of the administration of trimetazidine associated with hemodilution in the treatment of sudden deafness. Report of a multicenter study Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 107(5): 345-350
Simon, S.; Schönné, F.I. 1975: Kinetics of changes in dextran concentration in the blood of rabbits following administration of dextran preparations of various molecular weights Acta Pharmaceutica Hungarica 45(3): 120-127
Ji, J.; Fang, X.-L. 2008: Clinical observation on warming-removing obstruction needling method for treatment of sudden tinnitus and deafness Zhongguo Zhen Jiu 28(5): 353-355
Kawiak, W.; Pilarczyk, M.; Jarosz, M.; Gieracz-Nazar, A. 1987: Effect of low-molecular-weight dextran (40,000) on the levels of inorganic phosphorus and lipid-bound phosphorus in the blood of patients with a transient disorder of cerebral circulation Wiadomosci Lekarskie 40(16): 1088-1093
Feng, Y.; Zhang, J.; Li, S.; Liu, Y.; Zhang, Y.; Guo, Y.; Yang, M. 2017: Changes in nitric oxide, angiotensin Ⅱ angiopoietin-like protein 4 mRNA, neuregulin 1 mRNA, and platelet endothelial cell adhesion molecule-1 in rats with acute blood stasis induced by high-molecular-weight dextran Journal of Traditional Chinese Medicine 37(6): 846-853
Murty, B.S.; Prakash, V.; Rao, M.S. 1990: Determination of molecular weight and related hydrodynamic parameters of high molecular weight protein fraction from a few oilseeds Indian Journal of Biochemistry and Biophysics 27(5): 295-299
Eisner, M.; Grabowska, M.J.; Dobrohorska, H.; Nowotko, U. 1971: Possibility of erroneous evaluation of diabetes compensation during treatment with low-molecular dextran Polski Tygodnik Lekarski 26(51): 1982-1984
Bambasová, E.; Bílková, J.; Budínská, K. 1974: Papaverin in the treatment of geriatric patients Activitas Nervosa Superior 16(3): 191-192
Hirsch, S.; Dobrecki, J.J. 1974: Bloodletting and exchange transfusion of low-molecular dextran in the treatment of secondary polycythemia in chronic cor pulmonale Polski Tygodnik Lekarski 29(38): 1625-1628